/
CERO
$0.01+$0.00 (+1.83%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $10.00
0% from low
Exchange
OTC Link
CS
Borrow rate
46.92%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-9799.99
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $1.1M | $1.2M | $1.1M |
| Gross profit | $0 | $0 | −$1.1M | −$1.2M | −$1.1M |
| Gross margin | — | — | — | — | — |
| R&D | $9.1M | $9.8M | $5.3M | $6.3M | $10.4M |
| Operating income | −$332.0K | −$2.9M | −$2.9M | −$15.3M | −$18.5M |
| EBITDA | $403.1K | −$68.6K | −$2.4M | −$6.6M | −$17.4M |
| Net income | −$315.5K | −$667.7K | −$2.5K | −$7.7M | −$19.9M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -2.75 | -19.73 | -2497.20 | -6.87 | -22.58 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-2.50 | $-2.50–$-2.50 | 1 |
| 2027 | $0 | $-3.26 | $-3.26–$-3.26 | 1 |
| 2028 | $0 | $-2.76 | $-2.76–$-2.76 | 1 |
| 2029 | $52M | $-2.80 | $-2.80–$-2.80 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
CERO TERAPEUTICS HLDG INC
CERO TERAPEUTICS HLDG INC
Held by traders on TradeandTell
No one on the platform currently holds CERO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CERO as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-06-13 | 1-for-20reverse |
| 2025-01-08 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded CERO yet.
